Outlook Therapeutics Stock (NASDAQ: OTLK) stock price, news, charts, stock research, profile.
Open | $6.00 |
Close | $6.00 |
Volume / Avg. | 1.00M / 220.75K |
Day Range | $5.87 - $6.15 |
52 Wk Range | 4.09 - 18.00 |
Market Cap | $141.90M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 35 |
Short Interest | 15.09% |
Days to Cover | 17.78 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Outlook Therapeutics (NASDAQ:OTLK) through any online brokerage.
Other companies in Outlook Therapeutics’s space includes: Molecular Partners (NASDAQ:MOLN), Skye Bioscience (NASDAQ:SKYE), Adverum Biotechnologies (NASDAQ:ADVM), Adicet Bio (NASDAQ:ACET) and Agenus (NASDAQ:AGEN).
Outlook Therapeutics has a consensus price target of $21.95.
The stock price for Outlook Therapeutics (NASDAQ: OTLK) is $5.9984 last updated September 20, 2024 at 4:35 PM EDT.
There are no upcoming dividends for Outlook Therapeutics.
Outlook Therapeutics’s Q4 earnings are confirmed for Friday, December 20, 2024.
There is no upcoming split for Outlook Therapeutics.
Outlook Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.